Nettle & Cranberry Capsules for Prevention of Urinary Tract Infection

Status Recruiting

Clinical Trial Summary

This study investigates whether the oral intake of a nettle and cranberry complex capsule may prevent recurrent urinary tract infection (rUTI). Participants will be aged between 30 - 75 years of age, with confirmed diagnosis of UTI status. The participants will be assessed for several parameters and asked to take 2 nettle and cranberry complex capsules twice daily for 8 weeks. The parameters will include international prostate symptoms score (IPSS), overactive bladder symptom score (OABSS), international consultation on incontinence questionnaire - overactive bladder (ICIQ-OAB), 3-day bladder diary (3dBD), and urine routine.

Clinical Trial Description

Urinary tract infections (UTIs) are one of the most common bacterial infections affecting women. UTI occurs in 50-80% of women in the general population. About one in four women with one UTI episode will go on to develop frequent recurrences. Recurrent urinary tract infection (rUTI) is defined as repeated UTI with a frequency of at least two episodes in the preceding six months or three episodes in the past year. rUTI has been regarded as a substantial global healthcare problem. This investigation is a randomized, double-blind study. Subjects with confirmed diagnosis of rUTI are randomly assigned to control group or treatment group, and asked to orally intake 2 capsules of either placebo or nettle and cranberry complex capsules twice daily. Participants will be assessed for parameters, including international prostate symptoms score (IPSS) (male only), overactive bladder symptom score (OABSS), international consultation on incontinence questionnaire - overactive bladder (ICIQ-OAB), 3-day bladder diary (3dBD) and urine routine. The assessments are conducted at baseline, 4 weeks, and 8 weeks after the oral intake period. The parameters are used to compare and evaluate whether the nettle and cranberry complex capsule can prevention rUTI. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05880602
Study type	Interventional
Source	Chung Shan Medical University
Contact	David Pei-Cheng Lin, PhD
Phone	886-910-371286
Email	pcl@csmu.edu.tw
Status	Recruiting
Phase	N/A
Start date	July 5, 2023
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03235947` - Perioperative Fosfomycin in the Prophylaxis of Urinary Tract Infection in Kidney Transplant Recipients	Phase 4
Terminated	`NCT02198833` - Efficacy of Micro-Patterned Foley Catheter to Reduce Catheter-Associated Urinary Tract Infection	N/A
Withdrawn	`NCT01881165` - Cranberry on Urinary Tract Infections	Phase 4
Completed	`NCT01687114` - Urinary Proanthocyanidin-A2 as a Biomarker of Compliance to Intake of Cranberry Products	N/A
Completed	`NCT02357758` - Effects of Antibiotic Prophylaxis on Recurrent UTI in Children	Phase 4
Completed	`NCT01391793` - Corticosteroids for Children With Febrile Urinary Tract Infections	Phase 3
Completed	`NCT01219595` - Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women	N/A
Completed	`NCT00365430` - SAFE or SORRY? Patient Safety Study of the Prevention of Adverse Patient Outcomes	N/A
Recruiting	`NCT04502095` - Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy	Phase 4
Completed	`NCT00976963` - Single Dose Monurol for Treatment of Acute Cystitis	N/A
Recruiting	`NCT02568800` - Prolonged Infusion Cefepime and Nosocomial Infections	Phase 3
Completed	`NCT02785445` - Healthy.io Method Comparison & User Performance Study	N/A
Completed	`NCT02216253` - L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract to Prevent Postoperative Urinary Tract Infection.	N/A
Completed	`NCT01478620` - Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI)	Phase 3
Completed	`NCT01054690` - Silver Alloyed Urinary Catheters and Incidence of Catheter Acquired Urinary Tract Infections (UTI)	N/A
Completed	`NCT00371631` - Colonizing Neurogenic Bladders With Benign Flora	Phase 1
Terminated	`NCT03697993` - Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)	Phase 4
Terminated	`NCT01803919` - Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients	N/A
Enrolling by invitation	`NCT01231737` - Efficacy of Two Prophylactic Schedules (Prulifloxacin Versus Phosphomycin)	Phase 2
Completed	`NCT01763008` - A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Nettle and Cranberry Capsules for Prevention of Urinary Tract Infection

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms